Hartman Institute for Therapeutic Organ Regeneration

Use of zebrafish in chemical biology and drug discovery.

TitleUse of zebrafish in chemical biology and drug discovery.
Publication TypeJournal Article
Year of Publication2013
AuthorsDas BC, McCormick L, Thapa P, Karki R, Evans T
JournalFuture Med Chem
Volume5
Issue17
Pagination2103-16
Date Published2013 Nov
ISSN1756-8927
KeywordsAnimals, Drug Discovery, Humans, Models, Animal, Pharmacological Phenomena, Toxicity Tests, Zebrafish
Abstract

<p>The zebrafish (Danio rerio) is a small, tropical, freshwater fish that has emerged as a powerful vertebrate model organism for studying genetics and development. Its small size, transparency, cost-effectiveness, close genome homology to humans compared with invertebrates, and capacity for genetic manipulation are all valuable attributes for an excellent animal model. There are additional advantages for using zebrafish specifically in drug discovery, including ease of exposure to chemicals in water. In effect, zebrafish can bridge a gap between in vitro and mammalian work, reducing the use of larger animals and attrition rates. In the drug-discovery process, zebrafish can be used at many stages, including target identification and validation, identification of lead compounds, studying structure-activity relationships and drug safety profiling. In this review, we highlight the potential for the zebrafish model to make the drug-discovery process simpler, more effective and cost-efficient.</p>

DOI10.4155/fmc.13.170
Alternate JournalFuture Med Chem
PubMed ID24215349
Grant ListAA020630 / AA / NIAAA NIH HHS / United States
AI093220 / AI / NIAID NIH HHS / United States
HL111400 / HL / NHLBI NIH HHS / United States
HL56182 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065